Xylem (XYL) Shares Slide After It Cuts Its 2026 Forecast
Xylem plunged 14.2% on Tuesday, its worst day in at least five years, after the water-technology company cut its 2026 earnings forecast to $5.40–5.45 a share.
What happened
Shares of Xylem (XYL), which sells equipment and services to move, treat and measure water, plunged 14.2% on Tuesday after it cut its forecast for the year.
Xylem now expects 2026 revenue of about $8.95 billion, down 1% from last year, after previously guiding to growth of 2%, it said in its results release. It cut its adjusted earnings forecast to $5.40–5.45 a share, from $5.55–5.70.
Third-quarter revenue fell 3% to $2.2 billion, which Xylem blamed on project timing and “more cautious spending decisions” by customers; analysts had expected $2.28 billion, according to StockStory and 24/7 Wall St. Adjusted earnings of $1.44 a share were a penny below the $1.45 analysts expected, according to Investing.com and StockStory. The shares closed at $92.86, down 14.2% from the previous close.
Why it matters
Orders tell a different story from sales. They rose 10% organically, which means excluding acquisitions, divestitures and currency moves, to $2.3 billion, and the adjusted EBITDA margin, a measure of operating profit, widened by 0.7 percentage point to 23.9%. That points to customers delaying projects rather than cancelling them, but investors had paid for growth this year and will now get none.
Xylem also said it plans to sell two businesses, Applied Water International and Specialty Flow Control, and will reorganize into three segments from 1 January 2027. “We’re moving with urgency to shape Xylem around the markets where our capabilities can deliver the greatest customer value and strongest long-term growth,” Chief Executive Matthew Pine said in the release.
What the market is telling us
Xylem’s shares moved 5% or more on 4 of the last 252 sessions, and Tuesday’s drop was the biggest of them; it was also the stock’s worst day in our five years of price data. The stock is down 31.8% this year, and at $92.86 it sits 39.3% below its 52-week closing high of $152.95 from 29 October 2025. That was its lowest close since 30 October 2023. $1,000 invested in Xylem five years ago would be worth $725 today.
Our view: the 10% rise in orders is the number to hold on to; if those orders turn into revenue next year, Tuesday’s cut will look like a timing problem rather than a demand problem.
Follow Xylem
Its stories collect under My stocks on the front page. For the daily email, subscribe to the newsletter.
Mostly Markets is for information and education only and isn't investment advice. Theo Park is a pen name. Prices are from Nasdaq and CNBC as of the time stated.
